FDA's draft guidance on laboratory-developed tests increases clinical and economic risk to adoption of pharmacogenetic testing

Kenneth D. Levy, Victoria M. Pratt, Todd C. Skaar, Gail H. Vance, David A. Flockhart

Research output: Contribution to journalComment/debate

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)725-727
Number of pages3
JournalJournal of clinical pharmacology
Volume55
Issue number7
DOIs
StatePublished - Jul 1 2015

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this